SMS Pharmaceuticals Ltd.

View in App
84.41 +1.51 ▲1.8%

01 June 2023, 04:01:00 PM
Volume: 2,920

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.smspharma.com
Market Cap 713.62 Cr.
Enterprise Value(EV) 958.66 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -0.83 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 32.05 Trailing Twelve Months Ending 2023-03
Book Value / Share 54.40 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.55 Calculated using Price: 84.41
Dividend Yield 0.36 Period Ending 2022-03
No. of Shares Subscribed 8.47 Cr. 84,652,030 Shares
FaceValue 1
About SMS Pharmaceuticals Ltd.
SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base. Having six multi product facilities in operation, one under development, and two research centers, SMS has truly graduated in to big league with more than 600 employees working for it.

SMS Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

SMS Pharmaceuticals Ltd. Performance

View details >>
1 Day
+1.82%
1 Week
-0.80%
1 Month
+4.69%
3 Month
+22.21%
6 Month
-0.64%
1 Year
+3.89%
2 Year
-47.77%
5 Year
+33.56%
10 Year
+237.64%

SMS Pharmaceuticals Ltd. Fundamental Ratios

View details >>
8 years 2007-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.11 17.57 12.99 15.00 13.67 9.76 16.07 15.41
Return on Capital Employed (%) 18.91 19.54 12.73 18.17 16.57 13.06 17.62 12.60
Return on Assets (%) 7.73 8.46 6.15 7.95 7.62 5.50 8.44 7.97

SMS Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 294 255 284 322 348 411 470 461
Non Curr. Liab. 162 91 97 94 114 206 193 164
Curr. Liab. 200 156 134 156 154 211 211 255
Minority Int.
Equity & Liab. 656 502 515 572 617 828 875 880
Non Curr. Assets 408 336 334 351 389 503 482 469
Curr. Assets 248 166 181 221 228 325 392 411
Misc. Exp. not W/O
Total Assets 656 502 515 572 617 828 875 880

SMS Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 612 445 465 465 412 563 520 522
Other Income 4 1 2 3 5 3 5 5
Total Income 615 447 467 468 417 567 525 527
Total Expenditure -522 -370 -372 -375 -332 -442 -405 -468
PBIDT 93 77 96 94 85 125 120 59
Interest -17 -16 -15 -12 -12 -11 -19 -22
Depreciation -19 -19 -20 -19 -22 -22 -32 -32
Taxation -15 -6 -20 -21 -18 -30 -1 -1
Exceptional Items
PAT 42 36 40 41 33 61 68 4
Minority Interest
Share Associate -1 -7 -9 -1 -1 2 -6 -9
Other Related Items
Consolidated Net Profit 41 28 32 40 32 63 62 -5
Adjusted EPS 5 3 4 5 4 7 7 -1

SMS Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 61 73 32 50 40 90 40
Cash Fr. Inv. -97 -39 -17 -35 -43 -152 -27
Cash Fr. Finan. 44 -33 -15 -13 -2 92 -7
Net Change 9 1 0 2 -5 31 6
Cash & Cash Eqvt 11 12 13 15 10 40 47

SMS Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 67.29 67.29 67.29 67.29 67.29 64.17 64.17 64.17 64.29
Public 32.71 32.71 32.71 32.71 32.71 35.83 35.83 35.83 35.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.24 10.24 10.24 10.24 10.24 10.73 10.73 10.73 10.71

SMS Pharmaceuticals Ltd. Announcements

View details >>
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Conference Call held on 26th May 2023.
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year 2022-23
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year 2022-2023

SMS Pharmaceuticals Ltd. Technical Scans

View details >>
Thu, 01 Jun 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
High Increase in 3 Months High Increase in 3 Months

SMS Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,934.33 987.50 +1.1%
Divi's Laboratories Ltd. 93,571.04 3,524.75 +2.1%
Cipla Ltd. 77,836.62 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. 75,790.17 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. 69,284.07 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. 60,079.14 1,775.15 -3.8%
Mankind Pharma Ltd. 56,008.27 1,398.15 +2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.96 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 51.32 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 27.78 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.82 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 84.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.26 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 41.95 1,398.15 +2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7.33 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 3.33 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.25 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.19 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 5.39 1,398.15 +2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 0.04 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,398.15 +2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,398.15 +2.9%

SMS Pharmaceuticals Ltd. FAQ's

What is SMS Pharmaceuticals share price?
Can I buy SMS Pharmaceuticals shares now?
What is the Dividend Yield of SMS Pharmaceuticals?
What is the Market Cap of SMS Pharmaceuticals?
What are the key metrics to analyse SMS Pharmaceuticals?
What is the 52 Week High and Low of SMS Pharmaceuticals?
What is the trend of SMS Pharmaceuticals share price?